BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17113280)

  • 1. Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours.
    Wei MQ; Ellem KA; Dunn P; West MJ; Bai CX; Vogelstein B
    Eur J Cancer; 2007 Feb; 43(3):490-6. PubMed ID: 17113280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of bacteria in anti-cancer therapies.
    Ryan RM; Green J; Lewis CE
    Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial targeted tumour therapy-dawn of a new era.
    Wei MQ; Mengesha A; Good D; Anné J
    Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies for cancer gene therapy: progress and opportunities.
    Cao S; Cripps A; Wei MQ
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):108-14. PubMed ID: 19671071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiogenesis and radiotherapy (vessels, anaemia, oxygen and radiosensitivity)].
    Lartigau E
    Bull Cancer; 2007 Jul; 94 Spec No():S197-202. PubMed ID: 17846005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumour-Clostridium phenomenon: 50 years of developmental research (Review).
    Schmidt W; Fabricius EM; Schneeweiss U
    Int J Oncol; 2006 Dec; 29(6):1479-92. PubMed ID: 17088987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.
    Coulter JA; McCarthy HO; Worthington J; Robson T; Scott S; Hirst DG
    Gene Ther; 2008 Apr; 15(7):495-503. PubMed ID: 18256696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hypoxia in canine cancer.
    Snyder SA; Dewhirst MW; Hauck ML
    Vet Comp Oncol; 2008 Dec; 6(4):213-23. PubMed ID: 19178681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiogenesis inhibitors and radiation therapy: concept and preliminary results].
    Mazeron R; Bourhis J; Deutsch E
    Bull Cancer; 2009 Mar; 96(3):299-310. PubMed ID: 19318308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated bacteria as effectors in cancer immunotherapy.
    Al-Ramadi BK; Fernandez-Cabezudo MJ; El-Hasasna H; Al-Salam S; Attoub S; Xu D; Chouaib S
    Ann N Y Acad Sci; 2008 Sep; 1138():351-7. PubMed ID: 18837910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic adjuvant therapy for pancreatic cancer and other solid tumours.
    Bagley KC
    Gut; 2008 Mar; 57(3):289-91. PubMed ID: 18268052
    [No Abstract]   [Full Text] [Related]  

  • 15. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium spores as anti-tumour agents.
    Van Mellaert L; Barbé S; Anné J
    Trends Microbiol; 2006 Apr; 14(4):190-6. PubMed ID: 16500103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and vascular targeting: relevance for hyperthermia.
    Horsman MR
    Int J Hyperthermia; 2008 Feb; 24(1):57-65. PubMed ID: 18214769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific gene delivery using genetically engineered bacteria.
    Theys J; Barbé S; Landuyt W; Nuyts S; Van Mellaert L; Wouters B; Anné J; Lambin P
    Curr Gene Ther; 2003 Jun; 3(3):207-21. PubMed ID: 12762480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments.
    Hoogsteen IJ; Marres HA; van der Kogel AJ; Kaanders JH
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):385-96. PubMed ID: 17433637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modification of the Hungate vessel for cultivation of facultative and obligate anaerobic bacteria].
    Chernyshenko DV
    Mikrobiol Z; 2000; 62(6):57-9. PubMed ID: 11247352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.